DeBacker Research Group
DeBacker Research Group
Tour
News
People
Events
Publications
Contact
2
Providing Mindful and Informed Health Care for Patients Who Are LGBTQ+: Perspectives for Clinical Audiology
Purpose: More than 7% of the U.S. population identifies as LGBTQ+ (lesbian, gay, bisexual, transgender, queer, and other identities), …
Shade Avery Kirjava
,
Douglas P. Sladen
,
J. Riley DeBacker
Cite
DOI
URL
Audiologists’ perceived value of ototoxicity management and barriers to implementation for at-risk cancer patients in VA: the OtoMIC survey
Abstract Purpose Platinum-based chemotherapies used to treat many types of cancers are ototoxic. Ototoxicity management (OtoM) to …
Dawn Konrad-Martin
,
Rachel Polaski
,
J. Riley DeBacker
,
Sarah M. Theodoroff
,
Angela Garinis
,
Cecilia Lacey
,
Kirsten Johansson
,
Rosemarie Mannino
,
Trisha Milnes
,
Michelle Hungerford
,
Khaya D. Clark
Cite
DOI
URL
Ototoxicity prognostic models in adult and pediatric cancer patients: a rapid review
J. R. DeBacker
,
G. P. McMillan
,
N. Martchenke
,
C. M. Lacey
,
H. R. Stuehm
,
M. E. Hungerford
,
D. Konrad-Martin
Cite
DOI
URL
Cochlear Preconditioning as a Modulator of Susceptibility to Hearing Loss
Ryan T. Harrison
,
J. Riley DeBacker
,
Monica Trevino
,
Eric C. Bielefeld
,
Edward Lobarinas
Cite
DOI
URL
Hearing Loss in Offspring Exposed to Antiretrovirals During Pregnancy and Breastfeeding
Over 27 million people worldwide currently receive daily antiretroviral therapy for the management of HIV/AIDS. In order to prevent the …
J. Riley DeBacker
,
Breanna Langenek
,
Eric C. Bielefeld
Cite
DOI
URL
Mild hearing loss in C57BL6/J mice after exposure to antiretroviral compounds during gestation and nursing.
There is evidence of ototoxicity from antiretrovirals (ARVs), and ARV therapy in pregnant/nursing mothers can expose offspring to these …
J Riley DeBacker
,
Bo Hua Hu
,
Eric C Bielefeld
Cite
DOI
Changing the time intervals between cisplatin cycles alter its ototoxic side effect
Eric C. Bielefeld
,
Alicia Gonzalez
,
J. Riley DeBacker
Cite
DOI
URL
Using auditory electrophysiology testing to define the high frequencies across non-human mammal species
While the human’s frequency range of audibility has been well documented at 20–20 000 Hz, the audible frequency ranges vary …
Eric Bielefeld
,
J. R. DeBacker
Cite
DOI
URL
The Impact of Speech Recognition Testing on State Anxiety in Young, Middle-Age, and Older Adults
Purpose This study assessed state anxiety as a function of speech recognition testing using three clinical measures of speech in noise …
Christina M. Roup
,
Donna E. Green
,
J. Riley DeBacker
Cite
DOI
URL
Cisplatin-induced threshold shift in the CBA/CaJ, C57BL/6J, BALB/cJ mouse models of hearing loss
J. Riley DeBacker
,
Ryan T. Harrison
,
Eric C. Bielefeld
Cite
DOI
URL
»
Cite
×